Gilead oncology：Our Science
Our Science
GileadandKiteOncology'sportfolioincludesfourapprovedmedicinesincludingTrodelvy®(sacituzumabgovitecan-hziy)andZydelig®(idelalisib)aswellas ...。其他文章還包含有：「Announcement」、「GileadandKiteOncologyDemonstrateGrowing...」、「GileadSciences」、「Gilead」、「GrowthinOncologyPrograms」、「MedicinesforVirology」、「Oncology」、「TowardHealthEquityOncologyGrant」、「Virology」
查看更多 離開網站
Announcement
https://www.gilead.com
Since the acquisition of Kite Pharma, Gilead has expanded its presence in oncology to become a leader in cell therapy, a new way of using a patient's own ...
Gilead and Kite Oncology Demonstrate Growing ...
https://www.gilead.com
Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA.
Gilead Sciences
https://www.gilead.com
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Gilead
https://www.fiercepharma.com
Gilead has set a lofty goal of pulling a third of its revenue from oncology by 2030. Together, the three drugs are on track to generate $3 billion this year, ...
Growth in Oncology Programs
https://www.gilead.com
Both Kite and Gilead are focused on life-changing cancer medicines. We are striving to fundamentally change the way we target difficult-to-treat cancers. It's a ...
Medicines for Virology
https://www.gilead.com
View Gilead's medicines available to people in the United States living with COVID-19, HIV, viral hepatitis, cancer and other conditions.
Oncology
https://www.gilead.com
We're innovating with next-generation therapies, combinations and technologies to help transform how cancer is treated. We're relentlessly pursuing greater ...
Toward Health Equity Oncology Grant
https://www.gilead.com
Gilead awarded $7.6M in grants to 24 U.S.-based organizations addressing barriers to breast cancer care. These evidence-based programs focus on patient ...
Virology
https://www.gilead.com
Meta Description Learn about the investigational medicines in Gilead's pipeline with the potential to help advance care in HIV, cancer, ...